JY
LTRN icon

Jeff Yass’s Lantern Pharma LTRN Stock Holding History

Jeff Yass’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-104,000
Closed -$915K – 12744
2024
Q1 		$915K Buy
+104,000
New +$556K ﹤0.01% 7120
2021
Q2 		– Sell
-17,900
Closed -$325K – 12966
2021
Q1 		$325K Buy
+17,900
New +$314K ﹤0.01% 10436

Other funds holding LTRN

EAM
Empery Asset Management New York $86.5M AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

Jeff Yass's LTRN Position: Q2 2026 in Review

Jeff Yass opened a new position in Lantern Pharma (LTRN) in Q2 2026: 14,073 shares worth $58.7K. The stake represents ﹤0.01% of the portfolio and ranks #12768 among its holdings. This is a return to the name: Jeff Yass previously reported a position in LTRN as recently as Q4 2025.

Jeff Yass first reported a position in LTRN in Q3 2021 and has held it in 12 quarters since. The position peaked at $279K in Q2 2024. 39 funds tracked by Wall St. Rank hold LTRN as of Q2 2026.

  • Jeff Yass held 14,073 shares of Lantern Pharma worth $58.7K as of Q2 2026.
  • Lantern Pharma was a new Jeff Yass position in Q2 2026.
  • Lantern Pharma made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12768 holding.
  • Jeff Yass first reported a position in Lantern Pharma in Q3 2021 and has held it in 12 quarters since.
  • Jeff Yass's Lantern Pharma position peaked at $279K in Q2 2024.
  • 39 funds tracked by Wall St. Rank held Lantern Pharma as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.